Mark De Rosch
CIK: 0001890320
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CRVO
CervoMed Inc.
Officer
Discretionary Trading P&L
Holdings
About De Rosch Mark
De Rosch Mark (SEC CIK 0001890320) files insider reports with the SEC as EVP, RA and GA and PgM of CervoMed Inc. (CRVO).
Signal8 holds 3 ownership filings by De Rosch Mark (1 Form 3, 2 Form 4), filed between May 23, 2025 and Oct 23, 2026. Those filings report 2 transactions, from Feb 11, 2026 to Oct 22, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on De Rosch Mark's filings is in BOSTON, MA.
Recent filings by De Rosch Mark
Other insiders filing for CervoMed Inc. (CRVO)
- Blackburn Kelly, EVP, Clinical Development
- Winton Matthew, Chief Commercial and Business
- BOGER JOSHUA S, Director
- ZAVRL FRANK, Director
- Sabbagh Marwan, Director
- Quigley David, Director